Editorial: Levodopa after five years.
作者信息
Swanson P D
出版信息
West J Med. 1974 Sep;121(3):228-9.
Abstract
摘要
相似文献
1
Editorial: Levodopa after five years.社论：左旋多巴治疗五年后
West J Med. 1974 Sep;121(3):228-9.
2
The protective role of levodopa in the human substantia nigra.左旋多巴在人黑质中的保护作用。
Adv Neurol. 2001;86:327-36.
3
The clinical relevance of levodopa toxicity in the treatment of Parkinson's disease.左旋多巴毒性在帕金森病治疗中的临床相关性。
Mov Disord. 2008;23 Suppl 3:S515-20. doi: 10.1002/mds.22146.
4
Rat model of Parkinson's disease with bilateral motor abnormalities, reversible with levodopa, and dyskinesias.具有双侧运动异常、左旋多巴可逆转及运动障碍的帕金森病大鼠模型。
Mov Disord. 2007 Mar 15;22(4):533-9. doi: 10.1002/mds.21308.
5
Levodopa enhances synaptic plasticity in the substantia nigra pars reticulata of Parkinson's disease patients.左旋多巴可增强帕金森病患者黑质网状部的突触可塑性。
Brain. 2009 Feb;132(Pt 2):309-18. doi: 10.1093/brain/awn322. Epub 2008 Dec 2.
6
[Drug therapy in Parkinson's disease].[帕金森病的药物治疗]
Ned Tijdschr Geneeskd. 1999 Jan 30;143(5):234-40.
7
[Biochemical bases of Parkinson disease].[帕金森病的生化基础]
Recenti Prog Med. 1984 Oct;75(10):889-901.
8
Is levodopa toxic to human substantia nigra?左旋多巴对人体黑质有毒性吗？
Mov Disord. 1997 Sep;12(5):634-8. doi: 10.1002/mds.870120503.
9
10
Levodopa/dopamine replacement strategies in Parkinson's disease--future directions.帕金森病中左旋多巴/多巴胺替代策略——未来方向
Mov Disord. 2008;23 Suppl 3:S613-22. doi: 10.1002/mds.22061.
本文引用的文献
1
Huntington's chorea. Deficiency of gamma-aminobutyric acid in brain.亨廷顿舞蹈病。大脑中γ-氨基丁酸缺乏。
N Engl J Med. 1973 Feb 15;288(7):337-42. doi: 10.1056/NEJM197302152880703.
2
Choline acetylase and glutamic acid decarboxylase in Huntington's chorea. A preliminary study.亨廷顿舞蹈病中的胆碱乙酰化酶和谷氨酸脱羧酶。一项初步研究。
Neurology. 1973 Sep;23(9):912-7. doi: 10.1212/wnl.23.9.912.
Zotero 插件